

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | locomotory exploration behavior (GO:0035641) | 6.45660481 |
| 2 | neuron cell-cell adhesion (GO:0007158) | 5.86597512 |
| 3 | amino acid import (GO:0043090) | 5.40466591 |
| 4 | * activated T cell proliferation (GO:0050798) | 4.74790287 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.71156859 |
| 6 | negative regulation of cell killing (GO:0031342) | 4.59972759 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.59972759 |
| 8 | L-amino acid import (GO:0043092) | 4.52668950 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.22080783 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.21742758 |
| 11 | exploration behavior (GO:0035640) | 4.20956399 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.02228263 |
| 13 | regulation of gamma-delta T cell activation (GO:0046643) | 3.94642540 |
| 14 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.88799324 |
| 15 | tolerance induction (GO:0002507) | 3.86576839 |
| 16 | negative T cell selection (GO:0043383) | 3.81672126 |
| 17 | leukocyte aggregation (GO:0070486) | 3.78239240 |
| 18 | negative thymic T cell selection (GO:0045060) | 3.71329528 |
| 19 | negative regulation of T cell mediated immunity (GO:0002710) | 3.68377768 |
| 20 | dermatan sulfate biosynthetic process (GO:0030208) | 3.66647020 |
| 21 | interferon-gamma production (GO:0032609) | 3.64767034 |
| 22 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.62201775 |
| 23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.58979768 |
| 24 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.58073698 |
| 25 | neuron recognition (GO:0008038) | 3.52617623 |
| 26 | positive regulation of tolerance induction (GO:0002645) | 3.52087753 |
| 27 | negative regulation of axon extension (GO:0030517) | 3.50933308 |
| 28 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.42419392 |
| 29 | presynaptic membrane assembly (GO:0097105) | 3.41238306 |
| 30 | myelination (GO:0042552) | 3.39956574 |
| 31 | myelination in peripheral nervous system (GO:0022011) | 3.36694354 |
| 32 | peripheral nervous system axon ensheathment (GO:0032292) | 3.36694354 |
| 33 | ensheathment of neurons (GO:0007272) | 3.31683196 |
| 34 | axon ensheathment (GO:0008366) | 3.31683196 |
| 35 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.31501549 |
| 36 | cellular response to epinephrine stimulus (GO:0071872) | 3.30047763 |
| 37 | regulation of tolerance induction (GO:0002643) | 3.29552270 |
| 38 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.29487768 |
| 39 | dermatan sulfate metabolic process (GO:0030205) | 3.26760116 |
| 40 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.24892122 |
| 41 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.23393731 |
| 42 | positive T cell selection (GO:0043368) | 3.21265117 |
| 43 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.17530154 |
| 44 | transmission of nerve impulse (GO:0019226) | 3.14436415 |
| 45 | dendritic spine morphogenesis (GO:0060997) | 3.14001213 |
| 46 | axonal fasciculation (GO:0007413) | 3.11118732 |
| 47 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.09503739 |
| 48 | presynaptic membrane organization (GO:0097090) | 3.08423561 |
| 49 | positive thymic T cell selection (GO:0045059) | 3.05018751 |
| 50 | positive regulation of granulocyte differentiation (GO:0030854) | 3.03750957 |
| 51 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.02903175 |
| 52 | Rap protein signal transduction (GO:0032486) | 3.01014494 |
| 53 | vocalization behavior (GO:0071625) | 3.00660806 |
| 54 | postsynaptic membrane organization (GO:0001941) | 3.00486272 |
| 55 | layer formation in cerebral cortex (GO:0021819) | 2.99996626 |
| 56 | negative regulation of axonogenesis (GO:0050771) | 2.99878349 |
| 57 | respiratory tube development (GO:0030323) | 2.98485443 |
| 58 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.93475672 |
| 59 | thymic T cell selection (GO:0045061) | 2.93087063 |
| 60 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.92576045 |
| 61 | * dendrite morphogenesis (GO:0048813) | 2.89517096 |
| 62 | neuronal ion channel clustering (GO:0045161) | 2.89247319 |
| 63 | T cell homeostasis (GO:0043029) | 2.89229716 |
| 64 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.89207758 |
| 65 | synaptic vesicle maturation (GO:0016188) | 2.88944527 |
| 66 | cellular response to interleukin-15 (GO:0071350) | 2.88525750 |
| 67 | heterotypic cell-cell adhesion (GO:0034113) | 2.87913446 |
| 68 | semaphorin-plexin signaling pathway (GO:0071526) | 2.86374158 |
| 69 | response to epinephrine (GO:0071871) | 2.85654045 |
| 70 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.82914262 |
| 71 | T cell selection (GO:0045058) | 2.82677141 |
| 72 | * antigen receptor-mediated signaling pathway (GO:0050851) | 2.81621874 |
| 73 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.81289502 |
| 74 | regulation of cell killing (GO:0031341) | 2.80752475 |
| 75 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.80425178 |
| 76 | axon ensheathment in central nervous system (GO:0032291) | 2.79850163 |
| 77 | central nervous system myelination (GO:0022010) | 2.79850163 |
| 78 | long-term synaptic potentiation (GO:0060291) | 2.78137419 |
| 79 | positive regulation of neurological system process (GO:0031646) | 2.76122410 |
| 80 | response to interleukin-15 (GO:0070672) | 2.76007543 |
| 81 | regulation of axon regeneration (GO:0048679) | 2.75761932 |
| 82 | regulation of neuron projection regeneration (GO:0070570) | 2.75761932 |
| 83 | regulation of B cell differentiation (GO:0045577) | 2.75403509 |
| 84 | positive regulation of cell killing (GO:0031343) | 2.75132492 |
| 85 | C4-dicarboxylate transport (GO:0015740) | 2.74277480 |
| 86 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.72449743 |
| 87 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.72234832 |
| 88 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.71916408 |
| 89 | nerve growth factor signaling pathway (GO:0038180) | 2.71249907 |
| 90 | regulation of transmission of nerve impulse (GO:0051969) | 2.69376439 |
| 91 | protein localization to synapse (GO:0035418) | 2.68504570 |
| 92 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.66956320 |
| 93 | response to methylmercury (GO:0051597) | 2.65861215 |
| 94 | glutamate receptor signaling pathway (GO:0007215) | 2.64830812 |
| 95 | establishment of nucleus localization (GO:0040023) | 2.64466065 |
| 96 | cortical actin cytoskeleton organization (GO:0030866) | 2.62601329 |
| 97 | substantia nigra development (GO:0021762) | 2.60589126 |
| 98 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.59132478 |
| 99 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.58567282 |
| 100 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.57488149 |
| 101 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.56745426 |
| 102 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.56745426 |
| 103 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.54943269 |
| 104 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.54943269 |
| 105 | signal complex assembly (GO:0007172) | 2.54672598 |
| 106 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.54540548 |
| 107 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.54210992 |
| 108 | * T cell receptor signaling pathway (GO:0050852) | 2.53901066 |
| 109 | synaptic vesicle exocytosis (GO:0016079) | 2.53007799 |
| 110 | positive regulation of B cell differentiation (GO:0045579) | 2.52050180 |
| 111 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.51939892 |
| 112 | negative regulation of adaptive immune response (GO:0002820) | 2.51502818 |
| 113 | regulation of T cell tolerance induction (GO:0002664) | 2.51031397 |
| 114 | negative regulation of B cell mediated immunity (GO:0002713) | 2.50770364 |
| 115 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.50770364 |
| 116 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.50466759 |
| 117 | negative regulation of neurotransmitter transport (GO:0051589) | 2.49387706 |
| 118 | regulation of extent of cell growth (GO:0061387) | 2.49226897 |
| 119 | regulation of collateral sprouting (GO:0048670) | 2.48721581 |
| 120 | T cell differentiation (GO:0030217) | 2.47638313 |
| 121 | alpha-beta T cell differentiation (GO:0046632) | 2.47320808 |
| 122 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.46415205 |
| 123 | cortical cytoskeleton organization (GO:0030865) | 2.45284909 |
| 124 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.43924291 |
| 125 | natural killer cell differentiation (GO:0001779) | 2.43876496 |
| 126 | B cell receptor signaling pathway (GO:0050853) | 2.43830815 |
| 127 | positive regulation of Rap GTPase activity (GO:0032854) | 2.42838626 |
| 128 | positive regulation of synapse assembly (GO:0051965) | 2.41854720 |
| 129 | regulation of regulatory T cell differentiation (GO:0045589) | 2.41618720 |
| 130 | cellular response to catecholamine stimulus (GO:0071870) | 2.41017796 |
| 131 | cellular response to monoamine stimulus (GO:0071868) | 2.41017796 |
| 132 | mast cell activation (GO:0045576) | 2.39786412 |
| 133 | * T cell costimulation (GO:0031295) | 2.39774341 |
| 134 | regulation of synaptic vesicle transport (GO:1902803) | 2.39254192 |
| 135 | negative regulation of neural precursor cell proliferation (GO:2000178) | 2.39215981 |
| 136 | cerebellar granule cell differentiation (GO:0021707) | 2.39195306 |
| 137 | positive regulation of interleukin-2 production (GO:0032743) | 2.38956802 |
| 138 | morphogenesis of an endothelium (GO:0003159) | 2.38857797 |
| 139 | endothelial tube morphogenesis (GO:0061154) | 2.38857797 |
| 140 | astrocyte differentiation (GO:0048708) | 2.38403152 |
| 141 | glutamate secretion (GO:0014047) | 2.38069895 |
| 142 | positive regulation of humoral immune response (GO:0002922) | 2.36943292 |
| 143 | regulation of axon extension (GO:0030516) | 2.36805580 |
| 144 | * lymphocyte costimulation (GO:0031294) | 2.36259778 |
| 145 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.36067690 |
| 146 | T cell migration (GO:0072678) | 2.36038240 |
| 147 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.35302467 |
| 148 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.35133536 |
| 149 | regulation of granulocyte differentiation (GO:0030852) | 2.34406586 |
| 150 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.32939609 |
| 151 | regulation of Rap GTPase activity (GO:0032317) | 2.29624328 |
| 152 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.29614846 |
| 153 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.27910731 |
| 154 | negative regulation of interleukin-12 production (GO:0032695) | 2.26651895 |
| 155 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.26111514 |
| 156 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.23312432 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.83043315 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.45744915 |
| 3 | AR_21572438_ChIP-Seq_LNCaP_Human | 3.02527612 |
| 4 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.71994915 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.63934274 |
| 6 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.61355259 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.49212078 |
| 8 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.46487825 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.37156684 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.29392823 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.24469650 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.24469650 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.21728014 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.14963725 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.09978300 |
| 16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.08236465 |
| 17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.05367607 |
| 18 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.99792246 |
| 19 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.98860105 |
| 20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.97369388 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.97179571 |
| 22 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.96012514 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.95206491 |
| 24 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.90230704 |
| 25 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.89814499 |
| 26 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.89067228 |
| 27 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.87221224 |
| 28 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.85589222 |
| 29 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.85046372 |
| 30 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.76760677 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 1.72944337 |
| 32 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.72838112 |
| 33 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.70270402 |
| 34 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.68057339 |
| 35 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.67630905 |
| 36 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.62042081 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.61709232 |
| 38 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.59008680 |
| 39 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.58472264 |
| 40 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.58397790 |
| 41 | MAF_26560356_Chip-Seq_TH1_Human | 1.57589741 |
| 42 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.56007475 |
| 43 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.54948324 |
| 44 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.52720545 |
| 45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.49726536 |
| 46 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.48583673 |
| 47 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.48071005 |
| 48 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.48061198 |
| 49 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.44485953 |
| 50 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.43690669 |
| 51 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.41720021 |
| 52 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.39644748 |
| 53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.39126792 |
| 54 | MAF_26560356_Chip-Seq_TH2_Human | 1.38990694 |
| 55 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.38582052 |
| 56 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.36552056 |
| 57 | TP53_16413492_ChIP-PET_HCT116_Human | 1.35986953 |
| 58 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.34804055 |
| 59 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.33416892 |
| 60 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.31999170 |
| 61 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.31577296 |
| 62 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.31315149 |
| 63 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.31099864 |
| 64 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.30771431 |
| 65 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.30386383 |
| 66 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.29104056 |
| 67 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.28159731 |
| 68 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.27629545 |
| 69 | MYB_26560356_Chip-Seq_TH1_Human | 1.26955571 |
| 70 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.26659315 |
| 71 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26594678 |
| 72 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.26594678 |
| 73 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.26265776 |
| 74 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.25536867 |
| 75 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.25466709 |
| 76 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.24810276 |
| 77 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.23387362 |
| 78 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.21701315 |
| 79 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.21150766 |
| 80 | MYC_22102868_ChIP-Seq_BL_Human | 1.20424881 |
| 81 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.20346241 |
| 82 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.18811965 |
| 83 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.17978899 |
| 84 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.17810546 |
| 85 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.17264160 |
| 86 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.16217150 |
| 87 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.14933348 |
| 88 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14765624 |
| 89 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.13870074 |
| 90 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12816452 |
| 91 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.12707787 |
| 92 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12606499 |
| 93 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.12531459 |
| 94 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.11902753 |
| 95 | P300_19829295_ChIP-Seq_ESCs_Human | 1.11261737 |
| 96 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.10960943 |
| 97 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.10472837 |
| 98 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.10163784 |
| 99 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.09506744 |
| 100 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.08633192 |
| 101 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.07991442 |
| 102 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.06043766 |
| 103 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.05880388 |
| 104 | AR_19668381_ChIP-Seq_PC3_Human | 1.04368164 |
| 105 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04232049 |
| 106 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03854336 |
| 107 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02350741 |
| 108 | KDM2B_26808549_Chip-Seq_K562_Human | 1.02338006 |
| 109 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.02269437 |
| 110 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.01615542 |
| 111 | SPI1_23127762_ChIP-Seq_K562_Human | 0.99345837 |
| 112 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.98015155 |
| 113 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97847271 |
| 114 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.97581503 |
| 115 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.97246755 |
| 116 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96995309 |
| 117 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.96795251 |
| 118 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.96498787 |
| 119 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.96375299 |
| 120 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.96247592 |
| 121 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.95977664 |
| 122 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.94018404 |
| 123 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93679585 |
| 124 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.93367483 |
| 125 | * SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.93362341 |
| 126 | * CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.93174334 |
| 127 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93111538 |
| 128 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92515310 |
| 129 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92427474 |
| 130 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92280377 |
| 131 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.89823747 |
| 132 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.89749660 |
| 133 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.88600962 |
| 134 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87453715 |
| 135 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.85102041 |
| 136 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.84920753 |
| 137 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84585155 |
| 138 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.83758019 |
| 139 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.82808258 |
| 140 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.81530157 |
| 141 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.80639920 |
| 142 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.80349099 |
| 143 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.76960237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.44001741 |
| 2 | MP0003880_abnormal_central_pattern | 3.74155771 |
| 3 | MP0000920_abnormal_myelination | 2.95695959 |
| 4 | * MP0003635_abnormal_synaptic_transmissio | 2.85951294 |
| 5 | MP0005423_abnormal_somatic_nervous | 2.63167798 |
| 6 | MP0004742_abnormal_vestibular_system | 2.60133655 |
| 7 | MP0005623_abnormal_meninges_morphology | 2.53884425 |
| 8 | * MP0000778_abnormal_nervous_system | 2.35621834 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.35280698 |
| 10 | MP0003724_increased_susceptibility_to | 2.29275289 |
| 11 | MP0004134_abnormal_chest_morphology | 2.21060301 |
| 12 | * MP0002063_abnormal_learning/memory/cond | 2.20722190 |
| 13 | MP0003436_decreased_susceptibility_to | 2.19767266 |
| 14 | * MP0002064_seizures | 2.18532918 |
| 15 | * MP0009745_abnormal_behavioral_response | 2.17811671 |
| 16 | MP0003172_abnormal_lysosome_physiology | 2.17075277 |
| 17 | MP0004270_analgesia | 2.13559815 |
| 18 | MP0005387_immune_system_phenotype | 1.99962581 |
| 19 | MP0001790_abnormal_immune_system | 1.99962581 |
| 20 | MP0001486_abnormal_startle_reflex | 1.96194185 |
| 21 | MP0001440_abnormal_grooming_behavior | 1.94229114 |
| 22 | * MP0003763_abnormal_thymus_physiology | 1.93977789 |
| 23 | MP0004510_myositis | 1.86943769 |
| 24 | * MP0002572_abnormal_emotion/affect_behav | 1.85068005 |
| 25 | MP0002184_abnormal_innervation | 1.84996378 |
| 26 | MP0002272_abnormal_nervous_system | 1.81712914 |
| 27 | MP0004145_abnormal_muscle_electrophysio | 1.80376408 |
| 28 | MP0008569_lethality_at_weaning | 1.79213682 |
| 29 | MP0003329_amyloid_beta_deposits | 1.76167996 |
| 30 | MP0002405_respiratory_system_inflammati | 1.71980046 |
| 31 | MP0004381_abnormal_hair_follicle | 1.70298268 |
| 32 | MP0005025_abnormal_response_to | 1.68533236 |
| 33 | MP0003690_abnormal_glial_cell | 1.67956184 |
| 34 | MP0001968_abnormal_touch/_nociception | 1.62717330 |
| 35 | * MP0002452_abnormal_antigen_presenting | 1.61224945 |
| 36 | MP0000955_abnormal_spinal_cord | 1.59890800 |
| 37 | MP0004885_abnormal_endolymph | 1.59386395 |
| 38 | * MP0000716_abnormal_immune_system | 1.58484088 |
| 39 | MP0002734_abnormal_mechanical_nocicepti | 1.57940948 |
| 40 | MP0005171_absent_coat_pigmentation | 1.55280413 |
| 41 | MP0003634_abnormal_glial_cell | 1.55191499 |
| 42 | MP0002638_abnormal_pupillary_reflex | 1.51998672 |
| 43 | MP0003303_peritoneal_inflammation | 1.51283370 |
| 44 | MP0002067_abnormal_sensory_capabilities | 1.48541052 |
| 45 | MP0005257_abnormal_intraocular_pressure | 1.47598932 |
| 46 | MP0003787_abnormal_imprinting | 1.44390369 |
| 47 | MP0004185_abnormal_adipocyte_glucose | 1.41581242 |
| 48 | MP0009046_muscle_twitch | 1.41015085 |
| 49 | * MP0002419_abnormal_innate_immunity | 1.36585635 |
| 50 | MP0004858_abnormal_nervous_system | 1.32922986 |
| 51 | MP0000569_abnormal_digit_pigmentation | 1.31460221 |
| 52 | MP0005671_abnormal_response_to | 1.31312285 |
| 53 | MP0009785_altered_susceptibility_to | 1.30432089 |
| 54 | * MP0002882_abnormal_neuron_morphology | 1.29375241 |
| 55 | MP0001529_abnormal_vocalization | 1.28066017 |
| 56 | MP0004811_abnormal_neuron_physiology | 1.26196674 |
| 57 | MP0009780_abnormal_chondrocyte_physiolo | 1.24719013 |
| 58 | * MP0002722_abnormal_immune_system | 1.23520579 |
| 59 | MP0001958_emphysema | 1.21873658 |
| 60 | * MP0000689_abnormal_spleen_morphology | 1.20915878 |
| 61 | MP0001970_abnormal_pain_threshold | 1.20357314 |
| 62 | * MP0002557_abnormal_social/conspecific_i | 1.20190311 |
| 63 | MP0003091_abnormal_cell_migration | 1.16946444 |
| 64 | MP0002733_abnormal_thermal_nociception | 1.16207124 |
| 65 | MP0004924_abnormal_behavior | 1.13903315 |
| 66 | MP0005386_behavior/neurological_phenoty | 1.13903315 |
| 67 | MP0002736_abnormal_nociception_after | 1.13078017 |
| 68 | MP0003385_abnormal_body_wall | 1.12608025 |
| 69 | MP0001299_abnormal_eye_distance/ | 1.12455833 |
| 70 | * MP0002066_abnormal_motor_capabilities/c | 1.11990938 |
| 71 | * MP0002152_abnormal_brain_morphology | 1.09440153 |
| 72 | MP0010155_abnormal_intestine_physiology | 1.09217258 |
| 73 | * MP0002429_abnormal_blood_cell | 1.08111121 |
| 74 | MP0009333_abnormal_splenocyte_physiolog | 1.07435480 |
| 75 | MP0003632_abnormal_nervous_system | 1.06982004 |
| 76 | MP0009384_cardiac_valve_regurgitation | 1.06757139 |
| 77 | MP0002735_abnormal_chemical_nociception | 1.04478101 |
| 78 | MP0002089_abnormal_postnatal_growth/wei | 1.04316403 |
| 79 | MP0001485_abnormal_pinna_reflex | 1.04049628 |
| 80 | MP0000604_amyloidosis | 1.03754343 |
| 81 | MP0000751_myopathy | 1.03504686 |
| 82 | MP0003866_abnormal_defecation | 1.03095534 |
| 83 | MP0002009_preneoplasia | 1.01454276 |
| 84 | MP0004142_abnormal_muscle_tone | 1.00935153 |
| 85 | MP0002653_abnormal_ependyma_morphology | 0.97854642 |
| 86 | MP0004947_skin_inflammation | 0.96168705 |
| 87 | MP0000631_abnormal_neuroendocrine_gland | 0.94768704 |
| 88 | MP0005409_darkened_coat_color | 0.94054406 |
| 89 | MP0002822_catalepsy | 0.92685878 |
| 90 | MP0003045_fibrosis | 0.90603325 |
| 91 | MP0006276_abnormal_autonomic_nervous | 0.90587413 |
| 92 | MP0003300_gastrointestinal_ulcer | 0.90108119 |
| 93 | * MP0000703_abnormal_thymus_morphology | 0.89810879 |
| 94 | MP0003631_nervous_system_phenotype | 0.89252305 |
| 95 | MP0001501_abnormal_sleep_pattern | 0.87743831 |
| 96 | MP0001533_abnormal_skeleton_physiology | 0.87159510 |
| 97 | MP0000733_abnormal_muscle_development | 0.86651161 |
| 98 | MP0003121_genomic_imprinting | 0.85626727 |
| 99 | MP0001348_abnormal_lacrimal_gland | 0.84856140 |
| 100 | MP0003633_abnormal_nervous_system | 0.84772228 |
| 101 | MP0003861_abnormal_nervous_system | 0.83042402 |
| 102 | MP0001845_abnormal_inflammatory_respons | 0.82534659 |
| 103 | MP0006082_CNS_inflammation | 0.81828299 |
| 104 | MP0003122_maternal_imprinting | 0.81648256 |
| 105 | MP0001851_eye_inflammation | 0.78271038 |
| 106 | MP0005464_abnormal_platelet_physiology | 0.78252923 |
| 107 | * MP0002420_abnormal_adaptive_immunity | 0.77601521 |
| 108 | MP0001879_abnormal_lymphatic_vessel | 0.77404144 |
| 109 | MP0001819_abnormal_immune_cell | 0.76743563 |
| 110 | MP0004130_abnormal_muscle_cell | 0.76691270 |
| 111 | * MP0002148_abnormal_hypersensitivity_rea | 0.75808806 |
| 112 | MP0001943_abnormal_respiration | 0.75543132 |
| 113 | MP0002282_abnormal_trachea_morphology | 0.75183003 |
| 114 | MP0002998_abnormal_bone_remodeling | 0.75152745 |
| 115 | * MP0002752_abnormal_somatic_nervous | 0.74733212 |
| 116 | MP0001502_abnormal_circadian_rhythm | 0.74443195 |
| 117 | MP0003868_abnormal_feces_composition | 0.73706137 |
| 118 | MP0001963_abnormal_hearing_physiology | 0.72676747 |
| 119 | MP0003136_yellow_coat_color | 0.72674980 |
| 120 | * MP0001800_abnormal_humoral_immune | 0.72463872 |
| 121 | MP0005645_abnormal_hypothalamus_physiol | 0.72162082 |
| 122 | * MP0002398_abnormal_bone_marrow | 0.71922791 |
| 123 | MP0001984_abnormal_olfaction | 0.71670943 |
| 124 | MP0005310_abnormal_salivary_gland | 0.71581700 |
| 125 | MP0001986_abnormal_taste_sensitivity | 0.71148548 |
| 126 | MP0002166_altered_tumor_susceptibility | 0.70993190 |
| 127 | MP0000685_abnormal_immune_system | 0.69551847 |
| 128 | MP0002933_joint_inflammation | 0.68566269 |
| 129 | MP0008260_abnormal_autophagy | 0.67260812 |
| 130 | * MP0005000_abnormal_immune_tolerance | 0.67073762 |
| 131 | MP0000465_gastrointestinal_hemorrhage | 0.66853572 |
| 132 | * MP0002723_abnormal_immune_serum | 0.63778978 |
| 133 | MP0001873_stomach_inflammation | 0.62830949 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 3.47446836 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.46046490 |
| 3 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.46046490 |
| 4 | Abnormality of the corticospinal tract (HP:0002492) | 3.45023185 |
| 5 | Severe combined immunodeficiency (HP:0004430) | 3.42801854 |
| 6 | Peripheral hypomyelination (HP:0007182) | 3.34504576 |
| 7 | Atonic seizures (HP:0010819) | 3.32359055 |
| 8 | Myositis (HP:0100614) | 3.23576567 |
| 9 | Epiphyseal dysplasia (HP:0002656) | 3.15813238 |
| 10 | Optic neuritis (HP:0100653) | 3.12805818 |
| 11 | Retrobulbar optic neuritis (HP:0100654) | 3.12805818 |
| 12 | Abnormality of T cells (HP:0002843) | 3.10038456 |
| 13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.03881243 |
| 14 | Leukocytosis (HP:0001974) | 3.00983034 |
| 15 | Supranuclear gaze palsy (HP:0000605) | 2.98968101 |
| 16 | Neurofibrillary tangles (HP:0002185) | 2.96587847 |
| 17 | Focal seizures (HP:0007359) | 2.91767166 |
| 18 | Abnormality of eosinophils (HP:0001879) | 2.91671262 |
| 19 | Gastrointestinal infarctions (HP:0005244) | 2.87761492 |
| 20 | Focal motor seizures (HP:0011153) | 2.85323483 |
| 21 | Recurrent fungal infections (HP:0002841) | 2.85269608 |
| 22 | Orchitis (HP:0100796) | 2.81313485 |
| 23 | Spontaneous hematomas (HP:0007420) | 2.79216955 |
| 24 | Deep palmar crease (HP:0006191) | 2.77808702 |
| 25 | Cerebral inclusion bodies (HP:0100314) | 2.72937908 |
| 26 | Encephalitis (HP:0002383) | 2.71619436 |
| 27 | Akinesia (HP:0002304) | 2.70559375 |
| 28 | Obstructive sleep apnea (HP:0002870) | 2.66154656 |
| 29 | Action tremor (HP:0002345) | 2.65036623 |
| 30 | Spastic gait (HP:0002064) | 2.64660031 |
| 31 | Insidious onset (HP:0003587) | 2.63748418 |
| 32 | Termporal pattern (HP:0011008) | 2.63748418 |
| 33 | Meningitis (HP:0001287) | 2.62794766 |
| 34 | T lymphocytopenia (HP:0005403) | 2.62687596 |
| 35 | Broad ribs (HP:0000885) | 2.61870595 |
| 36 | Hypoplasia of the thymus (HP:0000778) | 2.61743506 |
| 37 | Autoimmune hemolytic anemia (HP:0001890) | 2.61340790 |
| 38 | Abnormality of binocular vision (HP:0011514) | 2.60594267 |
| 39 | Diplopia (HP:0000651) | 2.60594267 |
| 40 | Absent speech (HP:0001344) | 2.59271025 |
| 41 | Sensory axonal neuropathy (HP:0003390) | 2.58620178 |
| 42 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.54962555 |
| 43 | Recurrent cutaneous fungal infections (HP:0011370) | 2.54962555 |
| 44 | Increased IgM level (HP:0003496) | 2.54924294 |
| 45 | Visual hallucinations (HP:0002367) | 2.53060995 |
| 46 | Pulmonary infiltrates (HP:0002113) | 2.53057361 |
| 47 | Ankle clonus (HP:0011448) | 2.49189610 |
| 48 | Abnormality of T cell number (HP:0011839) | 2.48757075 |
| 49 | Eosinophilia (HP:0001880) | 2.47832817 |
| 50 | IgG deficiency (HP:0004315) | 2.45769145 |
| 51 | Recurrent abscess formation (HP:0002722) | 2.44164496 |
| 52 | Microglossia (HP:0000171) | 2.43391787 |
| 53 | Myokymia (HP:0002411) | 2.42974540 |
| 54 | Small epiphyses (HP:0010585) | 2.42904415 |
| 55 | Vasculitis (HP:0002633) | 2.40200851 |
| 56 | Premature skin wrinkling (HP:0100678) | 2.36266071 |
| 57 | Broad-based gait (HP:0002136) | 2.34579299 |
| 58 | Thyroiditis (HP:0100646) | 2.34549836 |
| 59 | Dysmetria (HP:0001310) | 2.33948243 |
| 60 | Combined immunodeficiency (HP:0005387) | 2.31859283 |
| 61 | Recurrent bacterial skin infections (HP:0005406) | 2.31115975 |
| 62 | Fetal akinesia sequence (HP:0001989) | 2.30903629 |
| 63 | Abnormality of the 4th metacarpal (HP:0010012) | 2.30456122 |
| 64 | Lymphopenia (HP:0001888) | 2.29507733 |
| 65 | Abnormality of the parathyroid morphology (HP:0011766) | 2.27659410 |
| 66 | Pachygyria (HP:0001302) | 2.26681954 |
| 67 | Short 4th metacarpal (HP:0010044) | 2.25326942 |
| 68 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.25326942 |
| 69 | Genetic anticipation (HP:0003743) | 2.24133428 |
| 70 | Hemoptysis (HP:0002105) | 2.21899444 |
| 71 | Amyotrophic lateral sclerosis (HP:0007354) | 2.19332464 |
| 72 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.19328560 |
| 73 | Pulmonary embolism (HP:0002204) | 2.18286631 |
| 74 | Chronic obstructive pulmonary disease (HP:0006510) | 2.17672216 |
| 75 | Obstructive lung disease (HP:0006536) | 2.17672216 |
| 76 | Granulocytopenia (HP:0001913) | 2.16995152 |
| 77 | Megalencephaly (HP:0001355) | 2.16084990 |
| 78 | Gingivitis (HP:0000230) | 2.14917434 |
| 79 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.12950189 |
| 80 | Progressive cerebellar ataxia (HP:0002073) | 2.12858480 |
| 81 | Urinary urgency (HP:0000012) | 2.12197544 |
| 82 | Recurrent bronchitis (HP:0002837) | 2.11982655 |
| 83 | Keratoconjunctivitis sicca (HP:0001097) | 2.11752094 |
| 84 | Chest pain (HP:0100749) | 2.11553484 |
| 85 | Mediastinal lymphadenopathy (HP:0100721) | 2.06640625 |
| 86 | Arterial tortuosity (HP:0005116) | 2.06626259 |
| 87 | Open mouth (HP:0000194) | 2.02988366 |
| 88 | Chin dimple (HP:0010751) | 2.02668028 |
| 89 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.99598813 |
| 90 | Hypoplasia of the brainstem (HP:0002365) | 1.99598813 |
| 91 | Adrenal hypoplasia (HP:0000835) | 1.99083217 |
| 92 | Stomatitis (HP:0010280) | 1.99081808 |
| 93 | Abnormality of macrophages (HP:0004311) | 1.99078730 |
| 94 | Pustule (HP:0200039) | 1.98781438 |
| 95 | Recurrent viral infections (HP:0004429) | 1.98724446 |
| 96 | Vitreoretinal degeneration (HP:0000655) | 1.97433325 |
| 97 | Epileptic encephalopathy (HP:0200134) | 1.96691238 |
| 98 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.96636838 |
| 99 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.96385347 |
| 100 | Mild short stature (HP:0003502) | 1.95592329 |
| 101 | Drooling (HP:0002307) | 1.95194472 |
| 102 | Excessive salivation (HP:0003781) | 1.95194472 |
| 103 | Macroorchidism (HP:0000053) | 1.94128727 |
| 104 | Keratoconjunctivitis (HP:0001096) | 1.94059573 |
| 105 | Recurrent skin infections (HP:0001581) | 1.93166579 |
| 106 | Lower limb asymmetry (HP:0100559) | 1.90692704 |
| 107 | Febrile seizures (HP:0002373) | 1.88269922 |
| 108 | Scanning speech (HP:0002168) | 1.88166444 |
| 109 | Intention tremor (HP:0002080) | 1.87754177 |
| 110 | Aqueductal stenosis (HP:0002410) | 1.86283363 |
| 111 | Mutism (HP:0002300) | 1.86051570 |
| 112 | Stereotypic behavior (HP:0000733) | 1.85892929 |
| 113 | Abnormality of the fingertips (HP:0001211) | 1.84938345 |
| 114 | Hypochromic anemia (HP:0001931) | 1.84885403 |
| 115 | Agammaglobulinemia (HP:0004432) | 1.83773797 |
| 116 | Relative macrocephaly (HP:0004482) | 1.83543883 |
| 117 | Dysdiadochokinesis (HP:0002075) | 1.82081677 |
| 118 | Hemiplegia (HP:0002301) | 1.81764818 |
| 119 | Vascular tortuosity (HP:0004948) | 1.80995710 |
| 120 | Supernumerary nipples (HP:0002558) | 1.80019420 |
| 121 | Scapular winging (HP:0003691) | 1.79137972 |
| 122 | Anomalous pulmonary venous return (HP:0010772) | 1.77447721 |
| 123 | Lower limb muscle weakness (HP:0007340) | 1.76548026 |
| 124 | Generalized hypotonia (HP:0001290) | 1.76369743 |
| 125 | Increased IgE level (HP:0003212) | 1.76321535 |
| 126 | Peritonitis (HP:0002586) | 1.76283564 |
| 127 | Apathy (HP:0000741) | 1.76136228 |
| 128 | Prolonged bleeding time (HP:0003010) | 1.75923336 |
| 129 | Oligodactyly (hands) (HP:0001180) | 1.75896192 |
| 130 | Heterochromia iridis (HP:0001100) | 1.75391342 |
| 131 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.75074309 |
| 132 | Trigonocephaly (HP:0000243) | 1.74585330 |
| 133 | Progressive inability to walk (HP:0002505) | 1.72460345 |
| 134 | Increased density of long bones (HP:0006392) | 1.71037088 |
| 135 | Sporadic (HP:0003745) | 1.70449535 |
| 136 | Abnormality of oral frenula (HP:0000190) | 1.69737016 |
| 137 | Panhypogammaglobulinemia (HP:0003139) | 1.69529420 |
| 138 | Bowel incontinence (HP:0002607) | 1.69130957 |
| 139 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.68390144 |
| 140 | Blue irides (HP:0000635) | 1.66450998 |
| 141 | Hypoplasia of the iris (HP:0007676) | 1.65829859 |
| 142 | Plagiocephaly (HP:0001357) | 1.64510964 |
| 143 | Inflammation of the large intestine (HP:0002037) | 1.64427150 |
| 144 | Mitral regurgitation (HP:0001653) | 1.63718837 |
| 145 | Truncal ataxia (HP:0002078) | 1.63642755 |
| 146 | Hypoplastic pelvis (HP:0008839) | 1.62112488 |
| 147 | Gastrointestinal inflammation (HP:0004386) | 1.61735411 |
| 148 | Onion bulb formation (HP:0003383) | 1.61704938 |
| 149 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.61140348 |
| 150 | Papilledema (HP:0001085) | 1.60600667 |
| 151 | Lower limb amyotrophy (HP:0007210) | 1.59512641 |
| 152 | Pointed chin (HP:0000307) | 1.59442037 |
| 153 | Abnormal auditory evoked potentials (HP:0006958) | 1.59289284 |
| 154 | Abnormality of the intervertebral disk (HP:0005108) | 1.58981070 |
| 155 | Increased variability in muscle fiber diameter (HP:0003557) | 1.58950671 |
| 156 | Supernumerary ribs (HP:0005815) | 1.58655207 |
| 157 | Absent hand (HP:0004050) | 1.57860189 |
| 158 | Dislocated radial head (HP:0003083) | 1.57795223 |
| 159 | Lissencephaly (HP:0001339) | 1.56239983 |
| 160 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.55982560 |
| 161 | Overgrowth (HP:0001548) | 1.55600181 |
| 162 | Abnormal eating behavior (HP:0100738) | 1.55473544 |
| 163 | Hypergammaglobulinemia (HP:0010702) | 1.55437461 |
| 164 | Joint swelling (HP:0001386) | 1.55220597 |
| 165 | Hyperthyroidism (HP:0000836) | 1.55053278 |
| 166 | Vertebral arch anomaly (HP:0008438) | 1.55009562 |
| 167 | Congenital hip dislocation (HP:0001374) | 1.53343805 |
| 168 | Limb dystonia (HP:0002451) | 1.53267269 |
| 169 | Tented upper lip vermilion (HP:0010804) | 1.53144580 |
| 170 | Diminished motivation (HP:0000745) | 1.53106904 |
| 171 | Gaze-evoked nystagmus (HP:0000640) | 1.51790957 |
| 172 | Slow saccadic eye movements (HP:0000514) | 1.51629522 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 4.30272739 |
| 2 | MARK1 | 3.47828952 |
| 3 | EPHB1 | 2.49529504 |
| 4 | TXK | 2.26061585 |
| 5 | MAPK13 | 2.24783931 |
| 6 | NTRK2 | 2.22845138 |
| 7 | ICK | 1.96113029 |
| 8 | MAP4K1 | 1.94197921 |
| 9 | PKN1 | 1.85543928 |
| 10 | SIK2 | 1.83970640 |
| 11 | RIPK4 | 1.77060862 |
| 12 | CASK | 1.74567608 |
| 13 | IRAK2 | 1.72615550 |
| 14 | EPHA4 | 1.68585809 |
| 15 | NTRK3 | 1.63597121 |
| 16 | PRKCH | 1.60604170 |
| 17 | STK39 | 1.57069826 |
| 18 | ITK | 1.54458071 |
| 19 | MAP3K4 | 1.53861890 |
| 20 | MINK1 | 1.52251620 |
| 21 | PAK6 | 1.50252706 |
| 22 | BTK | 1.50127041 |
| 23 | MARK2 | 1.47969936 |
| 24 | TYK2 | 1.46312025 |
| 25 | MAP3K10 | 1.45708403 |
| 26 | TAOK3 | 1.42835821 |
| 27 | IRAK1 | 1.41557343 |
| 28 | * TYRO3 | 1.40564480 |
| 29 | * CSK | 1.40348094 |
| 30 | UHMK1 | 1.39000178 |
| 31 | DMPK | 1.38868060 |
| 32 | KSR1 | 1.38444161 |
| 33 | TRIB3 | 1.37879167 |
| 34 | SYK | 1.34749290 |
| 35 | PRKCQ | 1.34423179 |
| 36 | PNCK | 1.33843183 |
| 37 | PRPF4B | 1.33785322 |
| 38 | CAMKK2 | 1.30883676 |
| 39 | MAP3K9 | 1.30365928 |
| 40 | KSR2 | 1.30287620 |
| 41 | ROCK2 | 1.28727185 |
| 42 | RET | 1.26117988 |
| 43 | RIPK1 | 1.25896539 |
| 44 | JAK3 | 1.24190434 |
| 45 | NTRK1 | 1.19062796 |
| 46 | EPHA3 | 1.18271258 |
| 47 | SGK2 | 1.12122572 |
| 48 | SIK3 | 1.07573567 |
| 49 | FGR | 1.07363232 |
| 50 | NLK | 1.04348205 |
| 51 | SGK223 | 1.03644491 |
| 52 | SGK494 | 1.03644491 |
| 53 | CDK5 | 1.01296773 |
| 54 | TEC | 1.00796961 |
| 55 | PAK3 | 0.97313321 |
| 56 | ROCK1 | 0.95917904 |
| 57 | * LCK | 0.95739228 |
| 58 | JAK2 | 0.92499296 |
| 59 | BLK | 0.92302726 |
| 60 | JAK1 | 0.92178475 |
| 61 | IKBKE | 0.91951441 |
| 62 | CSNK1G2 | 0.91383083 |
| 63 | TAOK1 | 0.91118770 |
| 64 | LIMK1 | 0.88967554 |
| 65 | HIPK2 | 0.88426128 |
| 66 | MAP3K13 | 0.87037725 |
| 67 | SGK3 | 0.86223011 |
| 68 | CAMK1G | 0.85493115 |
| 69 | PHKG1 | 0.84919034 |
| 70 | PHKG2 | 0.84919034 |
| 71 | ALK | 0.83580617 |
| 72 | IRAK4 | 0.81320628 |
| 73 | MARK3 | 0.80888740 |
| 74 | PLK2 | 0.80020425 |
| 75 | PKN2 | 0.79396716 |
| 76 | BRD4 | 0.78260915 |
| 77 | CSNK1G3 | 0.77303276 |
| 78 | TNK2 | 0.76827449 |
| 79 | * LYN | 0.76685604 |
| 80 | HCK | 0.76652898 |
| 81 | FGFR4 | 0.76309529 |
| 82 | MAP3K11 | 0.75664537 |
| 83 | GRK6 | 0.75152454 |
| 84 | MOS | 0.73102593 |
| 85 | FGFR3 | 0.72876216 |
| 86 | CSNK1A1L | 0.72710201 |
| 87 | STK11 | 0.72399768 |
| 88 | * FYN | 0.71011101 |
| 89 | * FES | 0.70709257 |
| 90 | PTK2 | 0.69910677 |
| 91 | PIM1 | 0.68425151 |
| 92 | MAP2K7 | 0.67352180 |
| 93 | KDR | 0.66523142 |
| 94 | PTK2B | 0.66314441 |
| 95 | * INSR | 0.64113627 |
| 96 | DYRK1A | 0.63604398 |
| 97 | NEK6 | 0.63532207 |
| 98 | CDK14 | 0.62670393 |
| 99 | DYRK2 | 0.61430730 |
| 100 | MAP3K7 | 0.61361276 |
| 101 | CAMKK1 | 0.60836707 |
| 102 | * PDGFRB | 0.60124897 |
| 103 | DYRK1B | 0.59924220 |
| 104 | MAP3K1 | 0.59664793 |
| 105 | MAPK7 | 0.59412114 |
| 106 | YES1 | 0.58294561 |
| 107 | MAP3K2 | 0.57719623 |
| 108 | FGFR2 | 0.57711073 |
| 109 | PDK1 | 0.56831662 |
| 110 | CLK1 | 0.56336098 |
| 111 | PRKD2 | 0.55240974 |
| 112 | PTK6 | 0.55170922 |
| 113 | CSNK1G1 | 0.55006058 |
| 114 | WNK1 | 0.53819106 |
| 115 | EPHB2 | 0.53780651 |
| 116 | SGK1 | 0.53696272 |
| 117 | PDGFRA | 0.53347065 |
| 118 | MAPK12 | 0.51939446 |
| 119 | STK38 | 0.51842365 |
| 120 | CDK15 | 0.51690593 |
| 121 | CAMK2A | 0.51466983 |
| 122 | MAPK10 | 0.50971478 |
| 123 | DAPK2 | 0.50577848 |
| 124 | GSK3A | 0.49200835 |
| 125 | ZAP70 | 0.48697392 |
| 126 | CDK18 | 0.48688693 |
| 127 | CAMK4 | 0.48340116 |
| 128 | MAP2K3 | 0.48043592 |
| 129 | OXSR1 | 0.47657526 |
| 130 | RAF1 | 0.47457166 |
| 131 | PASK | 0.47149881 |
| 132 | STK10 | 0.46984806 |
| 133 | PRKD3 | 0.46857814 |
| 134 | CDK11A | 0.46458127 |
| 135 | EEF2K | 0.45515238 |
| 136 | * SRC | 0.44255822 |
| 137 | KIT | 0.43516483 |
| 138 | BMPR2 | 0.43464827 |
| 139 | MAP2K4 | 0.43188026 |
| 140 | CAMK1 | 0.42184007 |
| 141 | CDK12 | 0.39571635 |
| 142 | PRKCZ | 0.39238930 |
| 143 | LRRK2 | 0.38856979 |
| 144 | CDK19 | 0.37061423 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.08574999 |
| 2 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.95436121 |
| 3 | * Axon guidance_Homo sapiens_hsa04360 | 1.80778272 |
| 4 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.80338741 |
| 5 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.74270708 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 1.67659137 |
| 7 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.67656043 |
| 8 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.63903044 |
| 9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.59221259 |
| 10 | Long-term depression_Homo sapiens_hsa04730 | 1.54276745 |
| 11 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.52722767 |
| 12 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.52141553 |
| 13 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.44873177 |
| 14 | Nicotine addiction_Homo sapiens_hsa05033 | 1.43021808 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.41115372 |
| 16 | Morphine addiction_Homo sapiens_hsa05032 | 1.35344884 |
| 17 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.31820429 |
| 18 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.31369241 |
| 19 | Circadian entrainment_Homo sapiens_hsa04713 | 1.31273496 |
| 20 | Colorectal cancer_Homo sapiens_hsa05210 | 1.30625077 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.29574744 |
| 22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.26293310 |
| 23 | * Viral myocarditis_Homo sapiens_hsa05416 | 1.25390914 |
| 24 | GABAergic synapse_Homo sapiens_hsa04727 | 1.24171194 |
| 25 | Glioma_Homo sapiens_hsa05214 | 1.23439187 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.20735288 |
| 27 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.20715655 |
| 28 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.20325691 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.19943819 |
| 30 | Leishmaniasis_Homo sapiens_hsa05140 | 1.17134194 |
| 31 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.16018013 |
| 32 | Salivary secretion_Homo sapiens_hsa04970 | 1.15723346 |
| 33 | Renin secretion_Homo sapiens_hsa04924 | 1.14908615 |
| 34 | Endometrial cancer_Homo sapiens_hsa05213 | 1.12474935 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.12265884 |
| 36 | Olfactory transduction_Homo sapiens_hsa04740 | 1.11709229 |
| 37 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.11601504 |
| 38 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.10198897 |
| 39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.10070302 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.09512356 |
| 41 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.09497617 |
| 42 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.09320537 |
| 43 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.08931775 |
| 44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.08390055 |
| 45 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.08361516 |
| 46 | Malaria_Homo sapiens_hsa05144 | 1.08091723 |
| 47 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.06841026 |
| 48 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.06601803 |
| 49 | Gap junction_Homo sapiens_hsa04540 | 1.06523877 |
| 50 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.06481583 |
| 51 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.05944656 |
| 52 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.04664572 |
| 53 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.04402792 |
| 54 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.02981046 |
| 55 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.02871775 |
| 56 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.02673087 |
| 57 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.01171973 |
| 58 | * Platelet activation_Homo sapiens_hsa04611 | 1.00826800 |
| 59 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.99726274 |
| 60 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.98779843 |
| 61 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.98556735 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.98273971 |
| 63 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.98247138 |
| 64 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.98168260 |
| 65 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.97192596 |
| 66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.96862492 |
| 67 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.92975785 |
| 68 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.92854743 |
| 69 | Shigellosis_Homo sapiens_hsa05131 | 0.92713731 |
| 70 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.92292340 |
| 71 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.89971622 |
| 72 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.86740885 |
| 73 | Allograft rejection_Homo sapiens_hsa05330 | 0.86354822 |
| 74 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86327483 |
| 75 | * Focal adhesion_Homo sapiens_hsa04510 | 0.86016873 |
| 76 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.84230892 |
| 77 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83929527 |
| 78 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.83630233 |
| 79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.83451338 |
| 80 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.83157494 |
| 81 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 0.81947090 |
| 82 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.81920673 |
| 83 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.81599861 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81222128 |
| 85 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.80722035 |
| 86 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.80187825 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.79958276 |
| 88 | Cocaine addiction_Homo sapiens_hsa05030 | 0.79708991 |
| 89 | * Measles_Homo sapiens_hsa05162 | 0.79631141 |
| 90 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78235877 |
| 91 | Endocytosis_Homo sapiens_hsa04144 | 0.77678335 |
| 92 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.77424662 |
| 93 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.76285409 |
| 94 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.75760268 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.75198740 |
| 96 | Tuberculosis_Homo sapiens_hsa05152 | 0.73729608 |
| 97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72925300 |
| 98 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.71502185 |
| 99 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.71469635 |
| 100 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.70701963 |
| 101 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69030075 |
| 102 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.68359086 |
| 103 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.67696626 |
| 104 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.67111742 |
| 105 | Prostate cancer_Homo sapiens_hsa05215 | 0.66738226 |
| 106 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.66186577 |
| 107 | Melanogenesis_Homo sapiens_hsa04916 | 0.65373108 |
| 108 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.64568487 |
| 109 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.63973006 |
| 110 | Apoptosis_Homo sapiens_hsa04210 | 0.63838434 |
| 111 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63606044 |
| 112 | HTLV-I infection_Homo sapiens_hsa05166 | 0.63572415 |
| 113 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.61786758 |
| 114 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.61305415 |
| 115 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.60480501 |
| 116 | Insulin secretion_Homo sapiens_hsa04911 | 0.59911462 |
| 117 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.58348610 |
| 118 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.57425644 |
| 119 | Hepatitis B_Homo sapiens_hsa05161 | 0.56524866 |
| 120 | Influenza A_Homo sapiens_hsa05164 | 0.56022243 |
| 121 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.55372887 |
| 122 | Salmonella infection_Homo sapiens_hsa05132 | 0.55162541 |
| 123 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.54819825 |
| 124 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.54589826 |

